The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.
David Antoniucci - Careggi Hospital, Firenze, Italy
Roxana Mehran - Mount Sinai Hospital, New York, US
Giuseppe DeLuca - Azienda Ospedaliera-Universitaria “Maggiore della Carità”, Novara, Italy
Holger Nef - University Hospital Giessen, Giessen, Germany
Mathias Vrolix - Ziekenhuis Oost Limburg, Genk, Belgium
Ahmed Khashaba - Al Dorrah Heart Care Hospital.Cairo, Egypt
